Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.
read more
Friday, November 03, 2023
Noramco, a prominent worldwide producer of active pharmaceutical ingredients (APIs), renowned for its proficiency in controlled substances, has successfully concluded the acquisition of the Cambrex Drug Product Business Unit, previously recognized as...
read more
Nonacus announced the commercial launch of a new service for Whole Genome Sequencing of SARS-CoV-2, developed to enable the UK government’s Test-To-Release scheme.
read more
Monday, February 08, 2021
Noble has announced the launch of “Human Factors Plus” (HF+), an expanded service to further optimize the patient self-administration experience by supporting its customers.
read more
NNIT, a provider of IT services and consultancy is now expanding the cooperation with AWS by signing a SPP agreement.
read more
NNIT announced it has signed an extension of its infrastructure outsourcing agreement with Novo Nordisk.
read more
Monday, November 16, 2020
NNIT acquires US-based Excellis, a specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
read more
Thursday, September 10, 2020
NKMax America has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the safety and tolerability of SNK01.
read more
Wednesday, March 20, 2019
NJII has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.
read more
Tuesday, November 05, 2024
NJ Bio, Inc. and Charles River Laboratories, Inc. announced a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of antibody drug conjugates (ADCs).
read more
Wednesday, April 01, 2026
NJ Bio and Ajinomoto Bio Pharma Services announced a research collaboration to expand access to AJICAP™, Aji Bio Pharma's site specific conjugation platform for NJ Bio's discovery stage and early development clients.
read more
Nitto Denko Corporation has announced the signing of a partnership agreement with global pharmaceutical company Daiichi Sankyo Company, Ltd. that will utilize Nitto's proprietary PassPort® active transdermal drug delivery technology.
read more
Nitto Denko Avecia announced the opening of its new oligonucleotide API manufacturing facility in Milford, MA.
read more
Wednesday, October 12, 2016
Nitto Denko Avecia Inc. has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals, both located in Irvine, CA.
read more
Thursday, September 03, 2020
MD Logistics and MD Express (collectively, MDL) have been acquired by Nippon Express U.S.A., (NEU), a U.S. based subsidiary of Nippon Express.
read more